Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Cancer survivors have been increasingly advocating for research into the long-term effects of their treatments. In this World View, Forster explains why cancer survivors must be included in every stage of the research process to ensure innovation in the field.
In this World View, Simone Badal proposes that we need to be continually producing a wider cross-section of cell lines, capturing different grades and stages of tumours among different ethnic groups, with an urgent focus on Black people, to ensure translatability in clinical trials.
